Le Lézard
Classified in: Environment, Health, Science and technology
Subject: Product/Service

New Strategic Vision for Biotechnology Innovation Organization


The Biotechnology Innovation Organization (BIO) today announced a new, strategic direction that will help guide it to achieving long-term goals while maintaining responsiveness to changing political headwinds.

Announcing the new vision, mission and purpose to member companies, BIO's recently appointed President and CEO, Dr. Michelle McMurry-Heath remarked, "We need to be the face and the voice of science?speaking up for the millions of families around the globe who depend upon our success. That means being bold, memorable, and?at times?provocative. But if we are as proud of our scientists and as committed to our patients and consumers as I know we are, then it is not only the best tactic, it is our duty."

After at least 106 one-on-one conversations with member companies, extensive strategic planning sessions, a broad membership survey and several focus groups, BIO outlined the new direction through

BIO plans to execute on the strategic direction though five different pillars:

  1. Be a voice of science and for science.
  2. Unite and empower biotech innovators and their ecosystem to improve lives.
  3. Remove barriers to innovation.
  4. Champion broad access to biotech breakthroughs and scientific quality.
  5. Catalyze resilient and sustainable bio-based economies.

The Board and staff of the nearly 1000-member organization plan to operationalize the five pillars beginning immediately. For more information on BIO's new strategic direction, visit www.bio.org/strategic-vision.

About BIO

BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world's largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.


These press releases may also interest you

at 17:00
US Fertility ("USF") is providing notice of a recent incident that may affect the security of certain individuals' protected health information. USF provides IT platforms and services to several infertility clinics, including Georgia Reproductive...

at 16:45
908 Devices, a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to...

at 16:35
CB2 Insights (CSE:CBII; OTCQB:...

at 16:15
Dr. Paul Lange, M.D., F.C.C.P., has been named medical director at Donor Alliance, the federally designated organ procurement organization serving Colorado and most of Wyoming. A board certified physician in pulmonary and critical care medicine,...

at 16:00
Amgen will present at the Evercore ISI Virtual HealthCONx Conference at 1:50 p.m. ET on Tuesday, Dec. 1, 2020. David M. Reese, M.D., executive vice president of Research and Development and Peter H. Griffith, executive vice president and chief...

at 16:00
E-Z-C Pak, the first physician formulated immune support pack composed of Echinacea, Zinc, and Vitamin C designed to reduce antibiotic overuse in cold and flu has surged in demand amid the COVID-19 outbreak. Company spokesperson Julianne Jahn...



News published on 27 october 2020 at 14:05 and distributed by: